297 related articles for article (PubMed ID: 16092112)
1. In vitro evaluation of biocompatibility of beta-tricalcium phosphate-reinforced high-density polyethylene; an orthopedic composite.
Homaeigohar SSh; Shokrgozar MA; Sadi AY; Khavandi A; Javadpour J; Hosseinalipour M
J Biomed Mater Res A; 2005 Oct; 75(1):14-22. PubMed ID: 16092112
[TBL] [Abstract][Full Text] [Related]
2. Effect of reinforcement particle size on in vitro behavior of beta-tricalcium phosphate-reinforced high-density polyethylene: a novel orthopedic composite.
Homaeigohar SS; Shokrgozar MA; Javadpour J; Khavandi A; Sadi AY
J Biomed Mater Res A; 2006 Jul; 78(1):129-38. PubMed ID: 16612817
[TBL] [Abstract][Full Text] [Related]
3. In vitro biological evaluation of beta-TCP/HDPE--A novel orthopedic composite: a survey using human osteoblast and fibroblast bone cells.
Homaeigohar SSh; Shokrgozar MA; Khavandi A; Sadi AY
J Biomed Mater Res A; 2008 Feb; 84(2):491-9. PubMed ID: 17618499
[TBL] [Abstract][Full Text] [Related]
4. Biocompatibility evaluation of HDPE-UHMWPE reinforced β-TCP nanocomposites using highly purified human osteoblast cells.
Shokrgozar MA; Farokhi M; Rajaei F; Bagheri MH; Azari Sh; Ghasemi I; Mottaghitalab F; Azadmanesh K; Radfar J
J Biomed Mater Res A; 2010 Dec; 95(4):1074-83. PubMed ID: 20878932
[TBL] [Abstract][Full Text] [Related]
5. In vitro osteoblastic response to 30 vol% hydroxyapatite-polyethylene composite.
Zhang Y; Tanner KE; Gurav N; Di Silvio L
J Biomed Mater Res A; 2007 May; 81(2):409-17. PubMed ID: 17117474
[TBL] [Abstract][Full Text] [Related]
6. Porous beta-tricalcium phosphate/collagen composites prepared in an alkaline condition.
Zou C; Weng W; Cheng K; Du P; Shen G; Han G; Guan B; Yan W
J Biomed Mater Res A; 2008 Oct; 87(1):38-44. PubMed ID: 18080301
[TBL] [Abstract][Full Text] [Related]
7. Proliferation and differentiation of osteoblast-like cells on apatite-wollastonite/polyethylene composites.
Rea SM; Brooks RA; Best SM; Kokubo T; Bonfield W
Biomaterials; 2004 Aug; 25(18):4503-12. PubMed ID: 15046941
[TBL] [Abstract][Full Text] [Related]
8. Beta-CaSiO3/beta-Ca3(PO4)2 composite materials for hard tissue repair: in vitro studies.
Ni S; Lin K; Chang J; Chou L
J Biomed Mater Res A; 2008 Apr; 85(1):72-82. PubMed ID: 17688291
[TBL] [Abstract][Full Text] [Related]
9. Novel bioactive composite bone cements based on the beta-tricalcium phosphate-monocalcium phosphate monohydrate composite cement system.
Huan Z; Chang J
Acta Biomater; 2009 May; 5(4):1253-64. PubMed ID: 18996779
[TBL] [Abstract][Full Text] [Related]
10. Calcium phosphates and glass composite coatings on zirconia for enhanced biocompatibility.
Kim HW; Georgiou G; Knowles JC; Koh YH; Kim HE
Biomaterials; 2004 Aug; 25(18):4203-13. PubMed ID: 15046910
[TBL] [Abstract][Full Text] [Related]
11. Porosity and pore size of beta-tricalcium phosphate scaffold can influence protein production and osteogenic differentiation of human mesenchymal stem cells: an in vitro and in vivo study.
Kasten P; Beyen I; Niemeyer P; Luginbühl R; Bohner M; Richter W
Acta Biomater; 2008 Nov; 4(6):1904-15. PubMed ID: 18571999
[TBL] [Abstract][Full Text] [Related]
12. Tissue-engineered bone formation using human bone marrow stromal cells and novel beta-tricalcium phosphate.
Liu G; Zhao L; Cui L; Liu W; Cao Y
Biomed Mater; 2007 Jun; 2(2):78-86. PubMed ID: 18458439
[TBL] [Abstract][Full Text] [Related]
13. Three-dimensional hierarchical composite scaffolds consisting of polycaprolactone, β-tricalcium phosphate, and collagen nanofibers: fabrication, physical properties, and in vitro cell activity for bone tissue regeneration.
Yeo M; Lee H; Kim G
Biomacromolecules; 2011 Feb; 12(2):502-10. PubMed ID: 21189025
[TBL] [Abstract][Full Text] [Related]
14. Biological evaluation of partially stabilized zirconia added HA/HDPE composites with osteoblast and fibroblast cell lines.
Yari Sadi A; Shokrgozar MA; Homaeigohar SS; Khavandi A
J Mater Sci Mater Med; 2008 Jun; 19(6):2359-65. PubMed ID: 18157686
[TBL] [Abstract][Full Text] [Related]
15. Suitability evaluation of sol-gel derived Si-substituted hydroxyapatite for dental and maxillofacial applications through in vitro osteoblasts response.
Balamurugan A; Rebelo AH; Lemos AF; Rocha JH; Ventura JM; Ferreira JM
Dent Mater; 2008 Oct; 24(10):1374-80. PubMed ID: 18417203
[TBL] [Abstract][Full Text] [Related]
16. Effect of rapidly resorbable bone substitute materials on the temporal expression of the osteoblastic phenotype in vitro.
Knabe C; Houshmand A; Berger G; Ducheyne P; Gildenhaar R; Kranz I; Stiller M
J Biomed Mater Res A; 2008 Mar; 84(4):856-68. PubMed ID: 17635025
[TBL] [Abstract][Full Text] [Related]
17. The effect of partially stabilized zirconia on the biological properties of HA/HDPE composites in vitro.
Sadi AY; Shokrgozar MA; Homaeigohar SSh; Hosseinalipour M; Khavandi A; Javadpour J
J Mater Sci Mater Med; 2006 May; 17(5):407-12. PubMed ID: 16688580
[TBL] [Abstract][Full Text] [Related]
18. In vitro and in vivo evaluation of a new nanocomposite, containing high density polyethylene, tricalcium phosphate, hydroxyapatite, and magnesium oxide nanoparticles.
Pourdanesh F; Jebali A; Hekmatimoghaddam S; Allaveisie A
Mater Sci Eng C Mater Biol Appl; 2014 Jul; 40():382-8. PubMed ID: 24857506
[TBL] [Abstract][Full Text] [Related]
19. Influence of TiO2 and Ag2O addition on tricalcium phosphate ceramics.
Seeley Z; Bandyopadhyay A; Bose S
J Biomed Mater Res A; 2007 Jul; 82(1):113-21. PubMed ID: 17269142
[TBL] [Abstract][Full Text] [Related]
20. Proliferation and osteoblastic differentiation of human bone marrow-derived stromal cells on akermanite-bioactive ceramics.
Sun H; Wu C; Dai K; Chang J; Tang T
Biomaterials; 2006 Nov; 27(33):5651-7. PubMed ID: 16904740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
